Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Imminent Madrigal, Viking Trial Readouts Will Shape NASH R&D Expectations
Nov 09 2022
•
By
Joseph Haas
Madrigal leads but Viking may be a close competitor in the NASH R&D race • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Strategy
More from Business